PharmaPoint: Non-Small Cell Lung Cancer – US Drug Forecast and Market … – PR Web (press release)

by lowes1 on October 3, 2013

PharmaPoint: Non-Small Cell Lung Cancer – US Drug Forecast and Market
PR Web (press release)
Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch of targeted therapies for patients 
LDK378 (Non-Small Cell Lung Cancer) – Forecast and Market Analysis to 2022 SBWire (press release)

all 2 news articles »

View full post on lung cancer – Google News

Leave a Comment

Previous post:

Next post: